ZA201807136B - Compositions for use in treating tendon degeneration - Google Patents

Compositions for use in treating tendon degeneration

Info

Publication number
ZA201807136B
ZA201807136B ZA2018/07136A ZA201807136A ZA201807136B ZA 201807136 B ZA201807136 B ZA 201807136B ZA 2018/07136 A ZA2018/07136 A ZA 2018/07136A ZA 201807136 A ZA201807136 A ZA 201807136A ZA 201807136 B ZA201807136 B ZA 201807136B
Authority
ZA
South Africa
Prior art keywords
compositions
treating tendon
tendon degeneration
degeneration
treating
Prior art date
Application number
ZA2018/07136A
Other languages
English (en)
Inventor
Colin D White
Edward S Ahn
Sekoni Daouda Noel
Original Assignee
Anika Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anika Therapeutics Inc filed Critical Anika Therapeutics Inc
Publication of ZA201807136B publication Critical patent/ZA201807136B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843Connective tissue
    • A61L27/386Ligaments, tendons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/10Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Closures For Containers (AREA)
ZA2018/07136A 2016-04-27 2018-10-25 Compositions for use in treating tendon degeneration ZA201807136B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662328396P 2016-04-27 2016-04-27
US201662367377P 2016-07-27 2016-07-27
PCT/US2017/029635 WO2017189723A1 (en) 2016-04-27 2017-04-26 Compositions for use in treating tendon degeneration

Publications (1)

Publication Number Publication Date
ZA201807136B true ZA201807136B (en) 2021-05-26

Family

ID=58709560

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/07136A ZA201807136B (en) 2016-04-27 2018-10-25 Compositions for use in treating tendon degeneration

Country Status (15)

Country Link
US (1) US10441677B2 (enExample)
EP (1) EP3448394B1 (enExample)
JP (1) JP6826657B2 (enExample)
KR (1) KR20190009303A (enExample)
CN (1) CN109562124A (enExample)
AU (1) AU2017257956B2 (enExample)
CA (1) CA3021764C (enExample)
IL (1) IL262507B (enExample)
MX (1) MX375382B (enExample)
NZ (1) NZ747413A (enExample)
RU (1) RU2018141386A (enExample)
SG (2) SG11201809197XA (enExample)
TW (2) TWI755392B (enExample)
WO (1) WO2017189723A1 (enExample)
ZA (1) ZA201807136B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018399962B2 (en) 2018-01-02 2024-11-14 Cartiheal (2009) Ltd. Implantation tool and protocol for optimized solid substrates promoting cell and tissue growth
JP2024006681A (ja) * 2022-07-04 2024-01-17 学校法人近畿大学 生体材料
WO2025096427A1 (en) * 2023-10-29 2025-05-08 Brown David Donaldson Methods for treating lower back pain with hyaluronic acid

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946819A (en) 1958-04-14 1960-07-26 Gen Aniline & Film Corp Process of producing carbodimides
DE1156401B (de) 1960-05-24 1963-10-31 Bayer Ag Verfahren zur Herstellung von Carbodiimiden
DE1149712B (de) 1961-11-14 1963-06-06 Bayer Ag Verfahren zur Herstellung von Carbodiimiden
US3644456A (en) 1964-08-12 1972-02-22 Upjohn Co Di((isocyanatobenzyl)-phenyl) carbodiimides and preparation of organic carbodiimides
US3972933A (en) 1974-05-28 1976-08-03 Monsanto Company Preparation of carbodiimides from ureas by dehydration
GB1476088A (en) 1975-04-03 1977-06-10 Ici Ltd Carbodiimides
DE2556760A1 (de) 1975-12-17 1977-06-30 Hoechst Ag Verfahren zur herstellung von carbodiimiden
GB1584153A (en) 1976-09-22 1981-02-04 Ici Ltd Carbodimides
US4066629A (en) 1976-10-28 1978-01-03 Celanese Corporation Process for preparing carbodiimides utilizing a phosphonium salt catalyst
US4098973A (en) 1977-01-31 1978-07-04 The Upjohn Company Compounds and process
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
DK0971961T3 (da) 1997-04-04 2003-03-24 Fidia Advanced Biopolymers Srl N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
WO2001041822A1 (en) 1999-12-09 2001-06-14 Biosyntech Canada Inc. Mineral-polymer hybrid composition
CA2416126C (en) 2000-07-28 2011-07-05 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid
IT1317359B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
ATE312076T1 (de) 2001-02-22 2005-12-15 Anika Therapeutics Inc Thiol-modifizierte hyaluronan-derivate
US20060272221A1 (en) 2001-11-29 2006-12-07 Treibacher Schleifmittel Gmbh Al2O3 and ZrO2 based abrasive grain, method for the production and use thereof
DE60323943D1 (de) 2002-02-21 2008-11-20 Encelle Inc Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen
ITPD20020064A1 (it) 2002-03-12 2003-09-12 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
ES2260616T3 (es) 2002-06-19 2006-11-01 Dr.H.C. Robert Mathys Stiftung Cemento hidraulico con base de fosfato de calcio destinado a uso quirurgico.
US8455458B2 (en) * 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
DE10257554B4 (de) 2002-12-10 2008-04-10 Treibacher Schleifmittel Gmbh Schleifkörner mit einer Ummantelung aus einem wässrigen Bindemittel und einer komplexen feinkörnigen Oxidverbindung, Verfahren zur Behandlung derartiger Schleifkörner sowie ihre Verwendung für kunstharzgebundene Schleifmittel
SI1677806T1 (sl) 2003-10-09 2009-06-30 Robert John Petrella Postopki za zdravljenje akutnega in s preobremenitvijo povzročenega zvina in natega z uporabo hialuronske kisline
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP1891984A1 (en) 2006-08-24 2008-02-27 Graftys Macroporous and highly resorbable apatitic calcium-phosphate cement
IT1393419B1 (it) 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
ES2819222T3 (es) * 2009-09-23 2021-04-15 Glenpharma Ab Composiciones y métodos para inducir o mejorar la reparación del tejido conectivo
AU2011217784B2 (en) * 2010-02-22 2014-10-09 Biomimetic Therapeutics, Llc. Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
CN103841927A (zh) 2011-06-09 2014-06-04 齐默尔膝部创造物公司 用于软骨下关节修复的器械和装置
EP2827914B1 (en) 2012-03-22 2019-05-08 TRB Chemedica International S.A. Method for repair of ligament or tendon
EP2900247B1 (en) * 2012-09-26 2018-01-17 Bone Therapeutics S.A. Compositions comprising solvent/detergent-treated plasma and hyaluronic acid for use in the treatment of muskuloskeletal disorders
JP6721514B2 (ja) 2014-02-20 2020-07-15 オルト リジェネレイティヴ テクノロジーズ インク.Ortho Regenerative Technologies Inc. 多血小板血漿と混合し、組織修復のためのインプラントを形成するための凍結乾燥ポリマー組成物及び/又は治療用関節内注射のための組成物

Also Published As

Publication number Publication date
US20170326271A1 (en) 2017-11-16
MX375382B (es) 2025-03-06
JP6826657B2 (ja) 2021-02-03
TWI755392B (zh) 2022-02-21
AU2017257956B2 (en) 2019-11-07
IL262507A (en) 2018-12-31
WO2017189723A1 (en) 2017-11-02
EP3448394A1 (en) 2019-03-06
RU2018141386A3 (enExample) 2020-05-27
TW201739457A (zh) 2017-11-16
SG11201809197XA (en) 2018-11-29
CA3021764C (en) 2021-01-19
MX2018012964A (es) 2019-06-10
RU2018141386A (ru) 2020-05-27
TW202114712A (zh) 2021-04-16
CA3021764A1 (en) 2017-11-02
SG10201913342UA (en) 2020-03-30
JP2019516784A (ja) 2019-06-20
KR20190009303A (ko) 2019-01-28
NZ747413A (en) 2020-09-25
US10441677B2 (en) 2019-10-15
EP3448394B1 (en) 2023-09-13
CN109562124A (zh) 2019-04-02
WO2017189723A9 (en) 2018-06-28
IL262507B (en) 2020-10-29
AU2017257956A1 (en) 2018-11-15
EP3448394C0 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
SI3490582T1 (sl) Sestavki za uporabo proti zdravljenju mielofibroze
IL258288B (en) Hair strengthening compound and hair strengthening method
ZA201706681B (en) Compositions and methods for treating anemia
PL3160234T3 (pl) Kompozycie do stosowania w profilaktyce i leczeniu wzrostu biofilmu na oczach, na rękach lub stopach
IL259992B (en) Compounds for use in methods for treating increased sensitivity to pain
IL251759A0 (en) Preparations and methods for treating insomnia
PT4215527T (pt) Composições e métodos para tratar a degradação retinal
IL271256A (en) Preparations and methods for the treatment of teopathy
SG11201606101WA (en) Compositions and methods for treating and preventing macular degeneration
PL3402575T3 (pl) Sposoby i kompozycje do traktowania zniszczonych włosów
IL250980A0 (en) Mucolytic agents for use in the treatment of pulmonary sarcoidosis
DK3250213T3 (en) Compositions containing arsenic for use in methods of treatment
IL269743A (en) Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions
IL250114A0 (en) Methods and compositions for the treatment of hiv-related diseases
ZA201605109B (en) Compositions and methods for treating neutropenia
ZA201807136B (en) Compositions for use in treating tendon degeneration
IL246637A0 (en) Preparations and methods for the treatment of intracerebral hemorrhage
GB2560769B (en) Compounds and compositions for use in treating psoriasis
GB201511447D0 (en) Compositions and methods for treating biofilms
GB201511051D0 (en) Compositions and methods for treating biofilms
GB201521083D0 (en) Compositions for treatment and methods thereof
GB201407949D0 (en) Compositions and methods for treating biofilms